Ngamcherdtrakul et al. [115] developed a multifunctional nanoparticle formulation, T-siHER2-NP(DTX), designed to co-deliver HER2-targeted siRNA, docetaxel (DTX), and TRZ to HER2-positive BC and BCBM. The gene discussed is ERBB2; the disease is breast cancer.